20n
Using AI to predict biochemistry for manufacturing and therapeutics
Y CombinatorWinter 2015InactiveHealthcareIndustrial BioArtificial IntelligenceBiotech
What they do
Problem
Using AI to predict biochemistry for manufacturing and therapeutics
Founders
Saurabh Srivastava
Founder/CEO
Work on building code capabilities for Nemotron at NVIDIA. Primarily focus is on pre-training, evals and data; some post-training. Previously: * Head of Code Research @ Essential AI (Ashish Vaswani's co) * YC W15 and S18: Code synthesis applied to bio and desktop automations respectively. * PhD / Postdoc: Code synthesis using theorem provers.
Chris Anderson
Founder/CSO
Company timeline
- YC batchWinter 2015
- StatusInactive
- Team size2 people
- LocationSan Francisco, CA, USA
